What is Rigel Pharmaceuticals's loans payable?

Rigel Pharmaceuticals (RIGL) reported loans payable of $44.86M in Q1 2026.

What does loans payable mean?

This represents the total amount of borrowed funds that the company is contractually obligated to repay to lenders, typically including both short-term and long-term portions. It serves as a primary indicator of the company's reliance on external debt financing to support its operations or capital projects. Analyzing this figure helps investors assess the company's debt burden and interest rate exposure.

Rigel Pharmaceuticals RIGL Loans Payable

Loans Payable at other companies

Stag IndustrialSTAG

$1.02B-0.1%

Easterly Government PropertiesDEA

$297.48M+8.8%

BFS

Saul CentersBFS

$138.98M+39.4%

Vornado RealtyVNO

$4.92B-13.4%

UMH

UMH PropertiesUMH

$27.96M-3.0%

KopinKOPN

$5.7M—

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LoansPayable.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's loans payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's loans payable?: Rigel Pharmaceuticals (RIGL) reported loans payable of $44.86M in Q1 2026.
What does loans payable mean?: This represents the total amount of borrowed funds that the company is contractually obligated to repay to lenders, typically including both short-term and long-term portions. It serves as a primary indicator of the company's reliance on external debt financing to support its operations or capital projects. Analyzing this figure helps investors assess the company's debt burden and interest rate exposure.